- A pharmacy that has obtained DEA authorization for an on-site controlled substance destruction program must meet which of the following witness requirements for destruction?
Answer: Two authorized individuals must witness and sign the destruction record.
DEA regulations require on-site controlled substance destruction to be witnessed by two authorized individuals who must sign the destruction record. The authorized witness categories are specified in DEA regulations. D correctly identifies the two-witness requirement and signature obligation. A is incorrect because witnesses are required; PIC documentation alone is not sufficient. B is incorrect because two witnesses are required, and their qualifications matter. C is incorrect because witnesses must meet the authorization criteria specified by DEA regulations, not simply be any staff members.
- A pharmacy receives a notice that a controlled substance product it has in inventory has been recalled. After quarantining the recalled stock, what is the appropriate disposal pathway for the recalled controlled substances?
Answer: Recalled controlled substances must be disposed of through DEA-authorized methods, such as reverse distribution or manufacturer return with authorization.
Recalled controlled substances must still follow DEA-authorized disposal pathways regardless of the reason for recall. Options include transfer to a reverse distributor, authorized return to the manufacturer, or DEA-approved on-site destruction. A correctly identifies these requirements. B is incorrect because a recall notice does not override DEA disposal requirements. C is incorrect because manufacturer returns of controlled substances require DEA documentation. D is incorrect because drain disposal is not an authorized method for pharmacy registrant disposal of recalled controlled substances.
- A patient asks a pharmacist what she should do with unused opioid pain tablets at home when no take-back location is available in her area. Which of the following best describes the FDA and DEA guidance for ultimate users in this situation?
Answer: Mix with undesirable substance, seal in container, dispose in trash; flush if on FDA flush list.
FDA and DEA guidance for ultimate users who cannot access a take-back program permits mixing medications with coffee grounds, kitty litter, or another undesirable substance and disposing in household trash; certain medications on the FDA flush list may also be flushed when take-back is unavailable. B correctly describes this guidance. A is incorrect because indefinite home storage of unused controlled substances is not recommended and disposal is encouraged. C is incorrect because pharmacies are not required to accept patient medications unless they are authorized collectors. D is incorrect because crushing tablets does not create an FDA-flushing exception; the flush list governs which specific medications may be flushed.
- A state pharmacy law requires pharmacies to report all controlled substance destruction events to the state board of pharmacy within 30 days. DEA Form 41 has already been submitted to the DEA. Does the pharmacy also need to report to the state board?
Answer: Yes, state and federal reporting obligations are independent; submitting DEA Form 41 satisfies the federal requirement, but the pharmacy must also separately comply with the state board reporting requirement.
State and federal reporting obligations for controlled substance destruction operate independently. Filing DEA Form 41 satisfies the federal DEA requirement; the pharmacy must also comply with any applicable state board reporting requirement. A correctly identifies this dual obligation. B is incorrect because federal law does not preempt state pharmacy board reporting requirements for controlled substance destruction. C is incorrect because the pharmacy may not choose one over the other when both are required by applicable law. D is incorrect because state board reporting requirements are not conditioned on law enforcement witness presence.
- A hospital pharmacy needs to dispose of expired Schedule II controlled substances. The hospital is not an authorized collector and does not have an on-site destruction program. Which of the following is the most appropriate disposal pathway?
Answer: Send the substances to a DEA-registered reverse distributor with proper documentation of transfer.
For a hospital without an on-site destruction program or authorized collector status, the appropriate pathway for Schedule II disposal is transfer to a DEA-registered reverse distributor with full documentation. D correctly identifies this pathway. A is incorrect because drain disposal is not an authorized method for hospital pharmacy registrant disposal of Schedule II controlled substances. B is incorrect because transfer to a hazardous waste vendor without DEA documentation does not satisfy controlled substance disposal requirements. C is incorrect because incineration with regular medical waste without DEA authorization is not compliant.
- A pharmacy's pharmacist-in-charge wants to dispose of an unusable controlled substance patch that was removed from a patient at the hospital. Which of the following best describes a compliant disposal method?
Answer: Dispose of the patch through a DEA-authorized reverse distributor or on-site destruction method.
A hospital pharmacy is a DEA registrant and must dispose of controlled substance waste -- including returned used patches -- through DEA-authorized registrant disposal pathways, such as DEA-authorized on-site destruction or transfer to a licensed reverse distributor, with required documentation. Folding the patch sticky-side in reduces residual drug exposure risk during handling. The FDA flush list applies to ultimate users (patients/caregivers) who lack access to a take-back program, not to DEA-registered pharmacy practitioners managing clinical waste. A is incorrect because regular medical waste disposal does not satisfy DEA controlled substance disposal requirements for a registrant. B is incorrect because returning a used patch to the manufacturer is not a standard DEA-authorized disposal pathway for clinical waste. C is incorrect because giving a used controlled substance patch to a patient is not compliant disposal.
- What documentation must a DEA-registered reverse distributor provide to a pharmacy after completing controlled substance destruction?
Answer: A destruction confirmation document detailing drug identity and quantities destroyed.
After completing controlled substance destruction, the reverse distributor is responsible for filing required DEA documentation and maintaining records of the destruction. The pharmacy should receive confirmation from the reverse distributor that the transferred substances were destroyed, with sufficient detail to support the pharmacy's own controlled substance accounting records. DEA regulations do not expressly require the reverse distributor to provide the pharmacy a copy of DEA Form 41 specifically, but the pharmacy must be able to document the transfer and disposition in its own records. A is incorrect because the reverse distributor has independent recordkeeping and reporting obligations. B is incorrect because a receipt of transfer alone does not confirm destruction; the pharmacy needs documentation establishing the substances were ultimately destroyed. D is incorrect because the pharmacy must maintain its own records of the transfer and subsequent disposition.
- A long-term care pharmacy must dispose of a deceased resident's controlled substance medications that were returned from the facility. What is the most compliant disposal pathway?
Answer: Utilize a DEA-authorized reverse distributor for compliant disposal of controlled substances.
For LTCF disposal of controlled substances, DEA regulations specifically recognize the installation of an authorized collection receptacle at the LTCF as a primary pathway, allowing the facility to collect and dispose of residents' controlled substances through a DEA-authorized collector. Use of a DEA-authorized reverse distributor is also permissible. B correctly identifies the DEA-recognized LTCF disposal options. A is incorrect because returning controlled substances to the prescribing physician is not an authorized disposal method under DEA regulations. C is incorrect because flushing is not an authorized disposal method for controlled substances held by a registered pharmacy or LTCF; flushing is an ultimate-user option for certain FDA flush-listed drugs, not a registrant disposal method. D is incorrect because transfer to a pharmacist employed by the same entity does not constitute compliant disposal.
- Which of the following substances is included on the FDA's flush list, permitting flushing when no take-back is available?
Answer: Certain opioids are on the FDA flush list for disposal when take-back options are unavailable.
The FDA flush list identifies specific medications that pose an exceptionally high risk of harm from accidental ingestion and for which flushing is recommended as a disposal method when take-back is unavailable. The list is limited to specific products. C correctly describes the flush list. A is incorrect because not all Schedule II opioids are on the flush list, and flushing is not the required method. B is incorrect because patch form alone does not determine flush list inclusion. D is incorrect because the FDA flush list exists and flushing is recommended for listed products when take-back is unavailable.
- A pharmacy wants to establish an on-site destruction program to dispose of controlled substances without using a reverse distributor. What DEA authorization is required for on-site destruction?
Answer: DEA prior authorization is required for on-site destruction of controlled substances.
DEA regulations require prior DEA authorization for an on-site controlled substance destruction program. Destruction must occur using an authorized method, witnessed appropriately, with all required documentation completed. B correctly identifies these requirements. A is incorrect because unrestricted on-site destruction without authorization is not permitted. C is incorrect because holding a DEA registration does not automatically authorize an on-site destruction program. D is incorrect because state board approval alone does not satisfy the federal DEA authorization requirement.
- A pharmacy receives a shipment of controlled substances that are damaged and cannot be dispensed. The pharmacy wants to return them to the manufacturer rather than using a reverse distributor. What documentation is required for this return shipment?
Answer: DEA Form 222 or CSOS is required for returning Schedule I and II controlled substances.
Returning controlled substances to a manufacturer requires appropriate documentation. Schedule I and II returns require a DEA Form 222 or CSOS equivalent; the transfer must be documented and records retained. A correctly identifies this requirement. B is incorrect because damaged returns are not documentation-exempt. C is incorrect because the original purchase invoice alone does not satisfy the DEA transfer documentation requirement. D is incorrect because a DEA variance is not the standard mechanism for a manufacturer return of damaged product.
- A retail pharmacy has become an authorized collector under DEA regulations and has placed a take-back collection receptacle in its waiting area. Which of the following best describes the compliance requirements for the collection receptacle?
Answer: The collection receptacle must be securely locked, mounted, and only accessible for removal by authorized personnel.
DEA authorized collector collection receptacles must meet specific construction and security requirements under 21 CFR 1317. The inner liner must be sealed and sent to a destruction facility; the pharmacy cannot open the receptacle to sort or review contents. A correctly identifies these requirements. B is incorrect because DEA specifications for construction and security must be met. C is incorrect because constant pharmacist supervision is not required for a properly secured collection receptacle. D is incorrect because the pharmacy may not open or sort the receptacle contents.
- Which DEA form is used to document the destruction of controlled substances?
Answer: DEA Form 41, which is specifically used to document the destruction of controlled substances.
DEA Form 41 is the Registrant Record of Controlled Substances Destroyed, used to document on-site destruction of controlled substances by a registrant. D correctly identifies this form. A is incorrect because DEA Form 222 is used for ordering Schedule I and II controlled substances, not destruction. B is incorrect because DEA Form 106 is used to report theft or significant loss, not destruction. C is incorrect because DEA Form 224 is the application for retail pharmacy DEA registration, not a destruction form.
- Under the DEA's Disposal Regulations (21 CFR Part 1317), authorized collectors may include which of the following?
Answer: DEA-registered entities with modified registration to accept controlled substances for disposal.
Under 21 CFR Part 1317, authorized collectors are DEA registrants such as pharmacies, hospitals, and clinics that have modified their registration to be authorized collectors. They may collect controlled substances from ultimate users for disposal. C correctly describes the authorized collector framework. A is incorrect because not every retail pharmacy is automatically an authorized collector; registration modification is required. B is incorrect because hospitals cannot simply accept patient returns without the authorized collector modification. D is incorrect because state environmental agencies are not DEA registrants and are not authorized collectors under the CSA framework.
- A patient asks the pharmacist whether she can bring unused opioids from a deceased family member to the pharmacy for disposal. Which of the following best describes the pharmacist's response at a pharmacy that is an authorized collector?
Answer: The pharmacy may accept unused opioids from family members of a deceased person as they are considered ultimate users under DEA rules.
DEA regulations define ultimate users to include family members or persons responsible for the care of a person who possessed controlled substances. Family members of a deceased individual are authorized to surrender those controlled substances to an authorized collector. B correctly identifies this provision. A is incorrect because DEA regulations specifically authorize family members and caregivers to surrender controlled substances belonging to deceased persons. C is incorrect because a death certificate is not required under DEA regulations for acceptance at an authorized collector. D is incorrect because prior DEA authorization is not required for each individual authorized collector transaction.
- A hospice patient has passed away and the hospice nurse is present in the home with remaining controlled substance medications. Under DEA regulations, what may the hospice nurse do with these medications?
Answer: The hospice nurse may assist in disposing of the medications in accordance with DEA and state regulations.
DEA regulations specifically authorize hospice personnel to witness and dispose of controlled substances belonging to deceased hospice patients in the home setting. B correctly identifies this DEA authorization. A is incorrect because returning controlled substances to the hospice pharmacy is not an authorized method for home disposal by a nurse. C is incorrect because DEA regional office contact is not required before a hospice nurse exercises her disposal authority. D is incorrect because DEA regulations specifically authorize hospice personnel, not only family members, to handle this disposal.
- The DEA hosted a National Prescription Drug Take Back event in a pharmacy's community. The pharmacy wants to participate by staffing an off-site collection location during the event. Under what authority may the pharmacy participate?
Answer: Pharmacies may participate by partnering with the DEA for sanctioned Take Back events under applicable regulations.
DEA National Prescription Drug Take Back events allow DEA-approved entities including pharmacies to participate as collection partners under the take-back event framework. This provides a temporary collection mechanism separate from permanent authorized collector status. A correctly describes this participation pathway. B is incorrect because pharmacies are recognized participants in DEA Take Back events. C is incorrect because prior authorized collector status is not required for take-back event participation. D is incorrect because take-back collection must be conducted under DEA authorization and coordination, not independently.
- A pharmacy wants to render its controlled substance waste non-retrievable as part of an on-site disposal process. Which of the following DEA standards for non-retrievability must be met?
Answer: Non-retrievable means the controlled substance is destroyed to prevent any potential for abuse, misuse, or diversion.
DEA defines non-retrievable as a state in which the controlled substance has been permanently altered -- through physical, chemical, or other means -- so it cannot be converted to a form that has value for abuse, misuse, diversion, or illicit distribution. D correctly states this definition. A is incorrect because packaging to prevent access is not the same as rendering non-retrievable; locked storage preserves the substance, while non-retrievability requires permanent alteration. B is incorrect because locked storage preserves the substance in its original form; non-retrievability requires permanent alteration, not merely preventing access. C is incorrect because dilution with water does not satisfy DEA's non-retrievability standard; reducing concentration is not the same as permanently altering the substance so it cannot be recovered or misused.
- When a pharmacy transfers controlled substances to a DEA-registered reverse distributor for disposal, what records must the pharmacy maintain?
Answer: Maintain records of the reverse distributor's details and an inventory of transferred controlled substances.
When transferring controlled substances to a reverse distributor, the pharmacy must maintain complete transfer records including the reverse distributor's identity and DEA registration number and a full inventory of what was transferred. D correctly identifies these recordkeeping obligations. A is incorrect because both the pharmacy and the reverse distributor have recordkeeping obligations; the pharmacy's obligation does not transfer with the drugs. B is incorrect because weight alone is insufficient to identify what was transferred. C is incorrect because drug names and date alone omit other required elements.
- Under DEA regulations, which of the following is a DEA-authorized method for a retail pharmacy to dispose of expired or unwanted controlled substances?
Answer: Transferring the controlled substances to a DEA-registered reverse distributor authorized to handle controlled substance disposal.
Under DEA regulations, one authorized disposal method for pharmacies is transferring controlled substances to a DEA-registered reverse distributor that is authorized to receive and handle controlled substance disposal. A correctly identifies this authorized method. B is incorrect because flushing is not a DEA-authorized standard disposal method for pharmacies; it is permitted only as a last resort in specific circumstances and is generally environmentally discouraged. C is incorrect because placing controlled substances in regular trash without special precautions is not an authorized DEA disposal method. D is incorrect because transfer to an arbitrary licensed pharmacist does not satisfy DEA disposal regulations.
